Financials • Investment Bankers/Brokers/Service
$81.77 ▼ -1.77
(-2.12%)
MKT CAP: $37.05B • VOL: 3.59M
52W L $59 52W H $99
IBKR // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.44B | $1.98B | $1.56B |
| YoY Revenue Growth % | +23.4% | +27.0% | — |
| Gross Profit | $1.07B | $869.9M | $685.1M |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $343.6M | $278.4M | $219.2M |
| Operating Margin % | 14.1% | 14.1% | 14.1% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $431.4M | $349.5M | $275.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $15.81B | $8.72B | $4.54B |
| Capital Expenditures (CapEx) | $109.8M | $89.0M | $70.1M |
| Free Cash Flow (FCF) | $15.70B | $8.64B | $4.47B |
| FCF Margin % | 643.5% | 436.8% | 287.3% |
| Return on Invested Capital (ROIC %) | 0.3% | 0.4% | 1.4% |
| Cash & Short-Term Equivalents | $4.96B | $3.63B | $2.24B |
| Total Debt (Short + Long Term) | $82.25B | $60.10B | $4.77B |
| Total Stockholders' Equity | $5.36B | $4.28B | $9.78B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR IBKR.